Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Fuji
US Department of Justice
Mallinckrodt
Julphar
Argus Health
Chinese Patent Office
AstraZeneca
US Army

Generated: January 19, 2019

DrugPatentWatch Database Preview

Interferon beta-1a - Biologic Drug Details

« Back to Dashboard

Summary for interferon beta-1a
Tradenames:2
Patents:85
Applicants:2
BLAs:2
Suppliers: see list2
Pharmacology for interferon beta-1a

US Patents for interferon beta-1a

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Try a Free Trial Pathologica LLC (San Francisco, CA) ➤ Try a Free Trial RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Try a Free Trial Avalyn Pharma Inc. (Seattle, WA) ➤ Try a Free Trial RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Try a Free Trial First Circle Medical, Inc. (Minneapolis, MN) ➤ Try a Free Trial RX search
Biogen AVONEX interferon beta-1a VIAL 103628 001 1996-05-17 ➤ Try a Free Trial First Circle Medical, Inc. (Minneapolis, MN) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for interferon beta-1a

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2015 00060 Denmark ➤ Try a Free Trial PRODUCT NAME: COBICISTAT ELLER ET FARMACEUTISK ACCEPTABELT SALT DERAF; REG. NO/DATE: EU/1/13/830/001-002 20130527
10/1996 Austria ➤ Try a Free Trial PRODUCT NAME: BETAFERON - INTERFERON BETA-1B
2015040,C2049506 Lithuania ➤ Try a Free Trial PRODUCT NAME: KOBICISTATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/13/830/001 - 002 20130524
2016000098 Germany ➤ Try a Free Trial PRODUCT NAME: DACLIZUMAB; REGISTRATION NO/DATE: EU/1/16/1107 20160701
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Teva
Medtronic
Queensland Health
Dow
AstraZeneca
Harvard Business School
Covington
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.